Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 17.44% vs 8.86% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -14.29% vs 59.62% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 41.86% vs 17.31% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs -92.86% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Biofrontera, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -40.94% vs 144.29% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 17.44% vs 8.86% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -185.71% vs 184.85% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.29% vs 59.62% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -135.71% vs 214.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 41.86% vs 17.31% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs -92.86% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






